Advertisement
Singapore markets close in 28 minutes
  • Straits Times Index

    3,272.81
    -14.94 (-0.45%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,115.22
    +36.36 (+0.45%)
     
  • Bitcoin USD

    64,361.78
    +416.09 (+0.65%)
     
  • CMC Crypto 200

    1,390.28
    -6.25 (-0.45%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,358.00
    +15.50 (+0.66%)
     
  • Crude Oil

    83.86
    +0.29 (+0.35%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,573.55
    +4.30 (+0.27%)
     
  • Jakarta Composite Index

    7,056.87
    -98.42 (-1.38%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Why Shares of Compugen Rose 16.5% on Wednesday

Why Shares of Compugen Rose 16.5% on Wednesday

Shares of Compugen (NASDAQ: CGEN), a clinical-stage biotech company that specializes in immunology therapies to treat cancer, saw its shares rise 16.5% on Wednesday. The stock closed on Tuesday at $1.03, then opened on Wednesday at $1.01, before jumping to $1.23 in the late afternoon and closing at $1.20. The stock has been volatile, with a 52-week low of $0.51 and a 52-week high of $4.88.